title: Synthesis and alkylation activity of a nitrogen mustard agent to penetrate the blood-brain barrier.
abstract: Nitrogen mustard agents are widely used for the clinical treatment of cancers. A nitrogen mustard (N-mustard) agent was synthesized utilizing nicotinic acid as the carrier of the alkylating substituent (-OCH2CH2N(CH2CH2Cl)2) that forms an ester group (R-C(O)-OR) on a heterocyclic ring. The N-mustard agent is a solid at room temperature and is stable for more than 6 weeks when stored at -10 degrees C. To determine the kinetics of alkylation activity a nucleophilic primary amine compound (4-chloroaniline) was placed in aqueous solution with the mustard agent at physiological pH 7.4 (pH of blood) and 37 degrees C. The alkylation reaction was found to be second-order with rate equation: rate = k2[N-mustard][Nu], where Nu = nucleophile and k2 = 0.0415 L/(mol x min). Pharmacological descriptors calculated showed values indicating a strong potential of penetrating the blood-brain barrier. The partition coefficient (Log P) of the mustard agent is 1.95 compared with 0.58 for nicotinic acid. Values of descriptors such as dipole, polar surface area, Log BB, molar refractivity, parachor, and violations of Rule of 5 were found to be 5.057 Debye, 42.44 A2, 0.662, 72.7 cm3, 607.7 cm3, and 0.0 for the N-mustard agent. Value of polar surface area for the mustard agent (42.44 A2) predicts that >90% of any amount present in the intestinal tract will be absorbed.
authors.affiliation: Medicinal Chemistry Laboratory, College of Arts and Sciences, University of Nebraska, Omaha, Nebraska 68182, USA. bartzatt@mail.unomaha.edu
authors.forename: Ronald L
authors.initials: RL
authors.lastname: Bartzatt
mesh_terms: D000465:Algorithms; D000478:Alkylation; D000814:Aniline Compounds / Q000737:chemistry / Q000493:pharmacokinetics; D000970:Antineoplastic Agents / Q000138:chemical synthesis / Q000737:chemistry / Q000493:pharmacokinetics; D001682:Biological Availability; D001812:Blood-Brain Barrier / Q000166:cytology / Q000187:drug effects*; D015195:Drug Design; D005450:Fluorescamine / Q000737:chemistry / Q000493:pharmacokinetics; D009525:Niacin / Q000737:chemistry / Q000493:pharmacokinetics; D009588:Nitrogen Mustard Compounds / Q000138:chemical synthesis* / Q000737:chemistry / Q000493:pharmacokinetics; D013056:Spectrophotometry, Ultraviolet; D013499:Surface Properties; D013696:Temperature; D013997:Time Factors
chemical_list: D000814:Aniline Compounds; D000970:Antineoplastic Agents; D009588:Nitrogen Mustard Compounds; D009525:Niacin; D005450:Fluorescamine; C004658:4-chloroaniline